Literature DB >> 23172145

Autism-related deficits via dysregulated eIF4E-dependent translational control.

Christos G Gkogkas1, Arkady Khoutorsky, Israeli Ran, Emmanouil Rampakakis, Tatiana Nevarko, Daniel B Weatherill, Cristina Vasuta, Stephanie Yee, Morgan Truitt, Paul Dallaire, François Major, Paul Lasko, Davide Ruggero, Karim Nader, Jean-Claude Lacaille, Nahum Sonenberg.   

Abstract

Hyperconnectivity of neuronal circuits due to increased synaptic protein synthesis is thought to cause autism spectrum disorders (ASDs). The mammalian target of rapamycin (mTOR) is strongly implicated in ASDs by means of upstream signalling; however, downstream regulatory mechanisms are ill-defined. Here we show that knockout of the eukaryotic translation initiation factor 4E-binding protein 2 (4E-BP2)-an eIF4E repressor downstream of mTOR-or eIF4E overexpression leads to increased translation of neuroligins, which are postsynaptic proteins that are causally linked to ASDs. Mice that have the gene encoding 4E-BP2 (Eif4ebp2) knocked out exhibit an increased ratio of excitatory to inhibitory synaptic inputs and autistic-like behaviours (that is, social interaction deficits, altered communication and repetitive/stereotyped behaviours). Pharmacological inhibition of eIF4E activity or normalization of neuroligin 1, but not neuroligin 2, protein levels restores the normal excitation/inhibition ratio and rectifies the social behaviour deficits. Thus, translational control by eIF4E regulates the synthesis of neuroligins, maintaining the excitation-to-inhibition balance, and its dysregulation engenders ASD-like phenotypes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23172145      PMCID: PMC4133997          DOI: 10.1038/nature11628

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  43 in total

Review 1.  PTEN signaling in autism spectrum disorders.

Authors:  Jing Zhou; Luis F Parada
Journal:  Curr Opin Neurobiol       Date:  2012-06-02       Impact factor: 6.627

Review 2.  Building excitatory and inhibitory synapses: balancing neuroligin partnerships.

Authors:  Joshua N Levinson; Alaa El-Husseini
Journal:  Neuron       Date:  2005-10-20       Impact factor: 17.173

3.  Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2.

Authors:  Alexander A Chubykin; Deniz Atasoy; Mark R Etherton; Nils Brose; Ege T Kavalali; Jay R Gibson; Thomas C Südhof
Journal:  Neuron       Date:  2007-06-21       Impact factor: 17.173

4.  Behavioral alterations in mice lacking the translation repressor 4E-BP2.

Authors:  Jessica L Banko; Maayan Merhav; Elad Stern; Nahum Sonenberg; Kobi Rosenblum; Eric Klann
Journal:  Neurobiol Learn Mem       Date:  2006-10-09       Impact factor: 2.877

5.  The Prader-Willi phenotype of fragile X syndrome.

Authors:  Stephen T Nowicki; Flora Tassone; Michele Y Ono; Jessica Ferranti; Marie Francoise Croquette; Beth Goodlin-Jones; Randi J Hagerman
Journal:  J Dev Behav Pediatr       Date:  2007-04       Impact factor: 2.225

6.  Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis.

Authors:  Dan Ehninger; Sangyeul Han; Carrie Shilyansky; Yu Zhou; Weidong Li; David J Kwiatkowski; Vijaya Ramesh; Alcino J Silva
Journal:  Nat Med       Date:  2008-06-22       Impact factor: 53.440

7.  The autistic neuron: troubled translation?

Authors:  Raymond J Kelleher; Mark F Bear
Journal:  Cell       Date:  2008-10-31       Impact factor: 41.582

8.  Characterization of autism in young children with tuberous sclerosis complex.

Authors:  Shafali S Jeste; Mustafa Sahin; Patrick Bolton; George B Ploubidis; Ayla Humphrey
Journal:  J Child Neurol       Date:  2007-12-26       Impact factor: 1.987

9.  Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity.

Authors:  Jeremy R Graff; Bruce W Konicek; Thomas M Vincent; Rebecca L Lynch; David Monteith; Spring N Weir; Phil Schwier; Andrew Capen; Robin L Goode; Michele S Dowless; Yuefeng Chen; Hong Zhang; Sean Sissons; Karen Cox; Ann M McNulty; Stephen H Parsons; Tao Wang; Lillian Sams; Sandaruwan Geeganage; Larry E Douglass; Blake Lee Neubauer; Nicholas M Dean; Kerry Blanchard; Jianyong Shou; Louis F Stancato; Julia H Carter; Eric G Marcusson
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

10.  The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP.

Authors:  Ilaria Napoli; Valentina Mercaldo; Pietro Pilo Boyl; Boris Eleuteri; Francesca Zalfa; Silvia De Rubeis; Daniele Di Marino; Evita Mohr; Marzia Massimi; Mattia Falconi; Walter Witke; Mauro Costa-Mattioli; Nahum Sonenberg; Tilmann Achsel; Claudia Bagni
Journal:  Cell       Date:  2008-09-19       Impact factor: 41.582

View more
  227 in total

Review 1.  mTOR in health and in sickness.

Authors:  Dritan Liko; Michael N Hall
Journal:  J Mol Med (Berl)       Date:  2015-09-22       Impact factor: 4.599

Review 2.  From the genetic architecture to synaptic plasticity in autism spectrum disorder.

Authors:  Thomas Bourgeron
Journal:  Nat Rev Neurosci       Date:  2015-09       Impact factor: 34.870

3.  A fine balance: Regulation of hippocampal Arc/Arg3.1 transcription, translation and degradation in a rat model of normal cognitive aging.

Authors:  Bonnie R Fletcher; Gordon S Hill; Jeffrey M Long; Michela Gallagher; Matthew L Shapiro; Peter R Rapp
Journal:  Neurobiol Learn Mem       Date:  2014-08-23       Impact factor: 2.877

4.  The mTORC1/4E-BP pathway coordinates hemoglobin production with L-leucine availability.

Authors:  Jacky Chung; Daniel E Bauer; Alireza Ghamari; Christopher P Nizzi; Kathryn M Deck; Paul D Kingsley; Yvette Y Yien; Nicholas C Huston; Caiyong Chen; Iman J Schultz; Arthur J Dalton; Johannes G Wittig; James Palis; Stuart H Orkin; Harvey F Lodish; Richard S Eisenstein; Alan B Cantor; Barry H Paw
Journal:  Sci Signal       Date:  2015-04-14       Impact factor: 8.192

5.  Issues in Clinical Epileptology: A View from the Bench. A Festschrift in Honor of Philip A. Schwartzkroin, PhD.

Authors:  Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2013-11       Impact factor: 7.500

6.  Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation.

Authors:  Janet L Oblinger; Sarah S Burns; Jie Huang; Li Pan; Yulin Ren; Rulong Shen; A Douglas Kinghorn; D Bradley Welling; Long-Sheng Chang
Journal:  Exp Neurol       Date:  2017-06-10       Impact factor: 5.330

7.  Inhibitory interneurons mediate autism-associated behaviors via 4E-BP2.

Authors:  Shane Wiebe; Anmol Nagpal; Vinh T Truong; Jeehyun Park; Agnieszka Skalecka; Alexander J He; Karine Gamache; Arkady Khoutorsky; Ilse Gantois; Nahum Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-19       Impact factor: 11.205

8.  Behavioral training reverses global cortical network dysfunction induced by perinatal antidepressant exposure.

Authors:  Xiaoming Zhou; Jordan Y-F Lu; Ryan D Darling; Kimberly L Simpson; Xiaoqing Zhu; Fang Wang; Liping Yu; Xinde Sun; Michael M Merzenich; Rick C S Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

9.  Common EIF4E variants modulate risk for autism spectrum disorders in the high-functioning range.

Authors:  Regina Waltes; Johannes Gfesser; Denise Haslinger; Katja Schneider-Momm; Monica Biscaldi; Anette Voran; Christine M Freitag; Andreas G Chiocchetti
Journal:  J Neural Transm (Vienna)       Date:  2014-05-13       Impact factor: 3.575

10.  Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion.

Authors:  Humsa S Venkatesh; Tessa B Johung; Viola Caretti; Alyssa Noll; Yujie Tang; Surya Nagaraja; Erin M Gibson; Christopher W Mount; Jai Polepalli; Siddhartha S Mitra; Pamelyn J Woo; Robert C Malenka; Hannes Vogel; Markus Bredel; Parag Mallick; Michelle Monje
Journal:  Cell       Date:  2015-04-23       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.